Cipher Pharmaceuticals Inc.

TSX:CPH Stock Report

Market Cap: CA$327.5m

Cipher Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 4/6

Cipher Pharmaceuticals has a total shareholder equity of $98.9M and total debt of $40.0M, which brings its debt-to-equity ratio to 40.5%. Its total assets and total liabilities are $153.9M and $55.0M respectively. Cipher Pharmaceuticals's EBIT is $9.9M making its interest coverage ratio -6.9. It has cash and short-term investments of $9.5M.

Key information

40.5%

Debt to equity ratio

US$40.00m

Debt

Interest coverage ratio-6.9x
CashUS$9.52m
EquityUS$98.86m
Total liabilitiesUS$55.00m
Total assetsUS$153.86m

Recent financial health updates

No updates

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Financial Position Analysis

Short Term Liabilities: CPH's short term assets ($29.1M) exceed its short term liabilities ($14.5M).

Long Term Liabilities: CPH's short term assets ($29.1M) do not cover its long term liabilities ($40.5M).


Debt to Equity History and Analysis

Debt Level: CPH's net debt to equity ratio (30.8%) is considered satisfactory.

Reducing Debt: CPH's debt to equity ratio has increased from 38.6% to 40.5% over the past 5 years.

Debt Coverage: CPH's debt is well covered by operating cash flow (32.7%).

Interest Coverage: CPH earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies